Sponsor:
UCLA
Code:
NCT05349474
Conditions
Secondary Progressive Multiple Sclerosis
Primary Progressive Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 30 - 65
Healthy Volunteers: Not accepted
Interventions
Metformin 500 Mg Oral Tablet, up to 4 tablets a day
Placebo oral tablet identical to metformin, up to 4 tablets a day
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by University of California, Los Angeles on 2025-05-01.